Stock markets in Asia moved higher at the start of trading on Monday, pulling back some of their losses from the end of last week. Oil prices surged as a conflict between Israel and Iran continued to escalate.

US stocks tumbled on Friday (June 13) after Israel launched a wave of airstrikes on Iran, pushing energy prices higher and adding another complication at a time of heightened geopolitical tensions. Here's a table showing how US stocks performed on Tuesday:

Source: Equitymaster

At present, the BSE Sensex is trading 38 points higher, and the NSE Nifty is trading 14 points higher.

Cipla, ONGC, and Bharti Airtel are among the top gainers today.

Tata Motors, Tata Steel, and Coal India are among the top losers today.

The BSE Midcap index is trading 0.7% lower, and the BSE Smallcap index is trading 1.4% higher.

Sectoral indices are trading on a negative note today, with stocks in the realty sector, metal sector, and auto sector witnessing selling pressure.

The rupee is trading at Rs 86.13 against the US dollar.

In commodity markets, gold prices are trading flat at Rs 100,296 per 10 grams today.
 

Sun Pharma's Halol plant Receives observations

Sun Pharmaceutical Industries Ltd's Halol manufacturing facility in Gujarat has come under renewed scrutiny from the United States Food and Drug Administration (US FDA), which issued eight observations following a recent inspection.

According to a regulatory filing by the company, the US FDA conducted a Good Manufacturing Practices (GMP) inspection at the Halol site from June 2 to June 13, 2025. At the end of the inspection, a Form 483 was issued with eight observations, indicating potential procedural or documentation lapses that need corrective action.

The Halol unit, one of Sun Pharma's largest manufacturing plants, has faced regulatory action in the past. It was last inspected in May 2022 and remains under an import alert after receiving a warning letter from the US FDA, effectively restricting the plant from shipping products to the US market.

Sun Pharma has said it will respond to the observations and take all necessary steps to address the concerns raised by the regulator.

NATCO Pharma Receives Observations

NATCO Pharma said that the US Food and Drug Administration (FDA) had conducted an inspection at the API manufacturing plant located in Mekaguda, Hyderabad, India, which was conducted from 09 to 13 of June 2025.

On conclusion of the inspection, the company received one observation in the Form-483.

The company believes that the observation is procedural in nature. The company is confident to address this observation comprehensively.

NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products.
 

DLF to Built Luxury Housing Project

Realty major DLF Ltd will invest around Rs 55 bn to develop a luxury housing project in Gurugram, as it seeks to achieve record sales bookings this fiscal on high demand.

According to sources, the company will soon launch an 18-acre project 'DLF Privana North' in Sector 76/77 Gurugram, comprising more than 1,150 apartments.

The estimated cost to develop this project is around Rs 55 bn, they added. This upcoming project is part of its 116-acre township 'DLF Privana'.

In this township, the company had last year launched and completely sold out two projects - 'DLF Privana West' and 'DLF Privana South' - for around Rs 128 bn.

In May 2024, DLF sold all 795 apartments for Rs 55.9 bn within three days of the launch of its 12.57-acre project 'Privana West'.

Before that, in January 2024, the company had sold 1,113 luxury apartments in Gurugram for Rs 72 bn within three days of the launch of its project 'DLF Privana South', which is spread over 25-acre.

The new project will be the third one in this large township.
 

Bajaj Finance Share Price in Focus

Bajaj Finance share price will be in focus on Monday as the stock will trade adjusted for its bonus issue and stock split. Bajaj Finance bonus issue and stock split was announced earlier while the company declared its Q4 results 2025.

Bajaj Finance bonus issue and stock split record date is fixed today, Monday, June 16.

On 29 April, Bajaj Finance had announced a dividend, stock split and bonus share issue for its shareholders. Bajaj Finance dividend record date was May 30 for the Rs 44 final dividend.

Bajaj Finance has declared a bonus issue in the ratio of 4:1. This means that the company will issue four bonus equity shares for every one equity share fully paid up held by the shareholder as on the record date.

Thus, after the stock split and the bonus share issue come into effect, an investor holding 100 Bajaj Finance shares will get 1000 shares.

More By This Author: